(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Traveling Alone: An Excursion of Self-Disclosure - 2The most effective method to Plan an Incineration Administration: A Bit by bit Guide.
- 34 DSLR Cameras for Amateurs in 2024
- 4Crime boss Steven Lyons set to be deported from Bali to Spain
- 5Tehran synagogue damaged by missile strike according to Iranian media
- IDF says up to 90% of Iran’s weapons industry could be hit within days
- Recalled "super greens" supplement linked to dozens of salmonella cases, CDC says
- When is MLK Day? Plus, the dates of when other federal holidays land in 2026.
- The 20 Most sultry Style of the Time
- An 'explosion' of solo-agers are struggling with rising costs and little support: 'I'm flying without a net'
- Most loved Fish Dish: What's Your Sea Pleasure?
- See a half-lit moon shine among the stars of Aquarius on Nov. 27
- Instructions to Adjust Work, Life, and Seeking after a Web based Advertising Degree
- Figure out How to Modify Your Pre-assembled Home for Greatest Solace and Stylish Allure
